NEW YORK--(BUSINESS WIRE)--Fera Pharmaceuticals is pleased to announce that it has been selected by Pragma Pharmaceuticals to launch Amoxicillin Extended-Release Tablets, the authorized generic for Moxatag®.
Craig Salmon, VP of Sales at Fera says, “By having an authorized generic available, it is our hope that more patients will gain access to this once-a-day antibiotic therapy helping to ensure greater adherence and compliance.”
About Fera Pharmaceuticals, LLC
Fera Pharmaceuticals is a privately held company. The company goal is to realize opportunities via acquisitions, in-licensing, developing and marketing abbreviated new drug applications (ANDAs), new drug applications (NDAs) and 505(b)(2) NDA products. Areas of interest include products that could benefit from lifecycle management with a special focus on niche markets. For more information visit www.ferapharma.com.